Privia Health
PRVA
151 hedge funds and large institutions have $2.03B invested in Privia Health in 2022 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 52 increasing their positions, 46 reducing their positions, and 30 closing their positions.
23% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 30
16% more capital invested
Capital invested by funds: $1.76B → $2.03B (+$274M)
13% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 46
3% more funds holding
Funds holding: 146 → 151 (+5)
3.35% more ownership
Funds ownership: 60.91% → 64.25% (+3.3%)
0% less call options, than puts
Call options by funds: $20M | Put options by funds: $20.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$29.5M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$18.4M |
| 3 |
OIA
OneDigital Investment Advisors
Overland Park,
Kansas
|
+$18.3M |
| 4 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
+$17M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$16.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$21.6M |
| 2 |
Millennium Management
New York
|
-$14.2M |
| 3 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$12.9M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$10.6M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$9.22M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PHK
176
Point72 Hong Kong
Hong Kong
| – | -$47K | -1,761 | Closed |
|
177
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$22K | -807 | Closed |
|
|
EWA
178
EverSource Wealth Advisors
Birmingham,
Alabama
| – | -$2K | -79 | Closed |
|
179
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
| – | -$1K | -30 | Closed |
|
|
C
180
Covestor
London,
United Kingdom
| – | -$102 | -4 | -22% |
|
PRVA Hedge Fund Activity: Q2 2022 in Review
151 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Privia Health (PRVA) for Q2 2022, worth a combined $2.03B — up 16% from $1.76B a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new PRVA positions and 30 closed out — a net gain of 7 holders — while 52 added to existing stakes and 46 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $29.5M. The largest seller was Point72 Asset Management, cutting an estimated $21.6M.
- 151 institutional investors held Privia Health (PRVA) as of Q2 2022, up from 146 in Q1 2022.
- Funds reported $2.03B of Privia Health stock for Q2 2022, up 16% quarter-over-quarter.
- 37 funds opened new Privia Health positions in Q2 2022 and 30 closed out, a net change of +7 holders.
- The largest Privia Health buyer in Q2 2022 was T. Rowe Price Associates, an estimated $29.5M added.
- The largest Privia Health seller in Q2 2022 was Point72 Asset Management, an estimated $21.6M sold.
Based on aggregated 13F filings for Q2 2022.